Osteocalcin, a 49-amino acid, gamma-carboxyglutamic acid-containing protein produced by the osteoblast, has been shown in laboratory animals to be a better marker of bone turnover than alkaline phosphatase. To determine serum osteocalcin levels in growing pigs, we isolated pure porcine osteocalcin and developed a double-antibody RIA. To evaluate the effects of dietary Ca and P levels on serum osteocalcin, 36 individually penned crossbred pigs (19.5 kg initial BW) were fed fortified corn-soybean meal diets (.95% lysine) containing four levels of Ca (.42, .66, .90, 1.14%) and P (.35, .55, .75, .95%) in a 30-d test. Increasing dietary Ca and P improved body weight gain quadratically (P < .02). Most bone traits improved quadratically (P < .05) with increasing Ca and P. Pigs were bled on d 0, 10, 20, and 30 to determine serum levels of alkaline phosphatase, 1,25-dihydroxyvitamin D3, and osteocalcin. Osteocalcin decreased (P < .02) linearly with increasing Ca and P on d 10, 20, and 30. However, this effect was much more pronounced on d 20 and 30. Alkaline phosphatase decreased with the first incremental increase in dietary Ca and P, but was not affected by higher levels on any day measured. Osteocalcin was inversely correlated with growth rate (r = -.54, P < .01), bone strength (r = -.57, P < .01), metacarpal ash (r = -.29, P < .10), femur ash (r = -.60, P < .01), and femur ash weight (r = -.65, P < .01). Similar results were found for 1,25-dihydroxyvitamin D3. Alkaline phosphatase was not correlated with performance or most bone traits on d 30. Based on this model, these results suggest that serum osteocalcin and 1,25-dihydroxyvitamin D3 are better predictors of bone mineralization and(or) turnover in pigs than serum alkaline phosphatase.

We conducted two experiments to evaluate the effects of recombinant porcine somatotropin (pST) on the P requirement of finishing pigs. Corn-soybean meal diets with varying levels of P were fed, and Ca was adjusted to maintain a Ca:P ratio of 1.1:1. In Exp. 1, 96 pigs were fed dietary P concentrations of .35, .45, and .65% from 75 to 109 kg BW. One-half of the pigs were injected daily with 4 mg of pST. Pigs treated with pST consumed less feed and gained more efficiently than untreated pigs (P < .01). Increasing the dietary P level produced linear (P < .05) improvements in most metacarpal-metatarsal (MM) and femur traits. Administration of pST increased (P < .02) bone weight, but it reduced (P < .03) bone strength and the percentage of ash. The increases in percentage of ash and ash accretion associated with increasing dietary P were more pronounced in pST-treated pigs than in untreated pigs (pST x P, P < .01). Experiment 2 consisted of 66 pigs fed six dietary P concentrations (.35, .50, .65, .80, .95, and 1.10%) from 72 to 114 kg. One-half of the pigs were injected daily with 4 mg of pST. Pigs treated with pST gained faster and more efficiently (P < .01) but consumed less feed than untreated pigs (P < .01). Increasing the dietary P level improved most of the bone traits. Administration of pST reduced (P < .01) MM strength and percentage ash in the MM and femurs, but it increased (P < .01) femur diameter and wall thickness. Bone strength and percentage ash were reduced in pST-treated pigs fed low dietary P; however, at higher dietary P, these traits were similar to or greater than those in untreated pigs (pST x P, P < .10). Generally, bone traits in pST-treated pigs reached a plateau at higher dietary P concentrations and at higher P intakes compared with those in untreated pigs. These results indicate that pST administration increases the dietary P level that is required to maximize bone traits in finishing pigs.

We investigated the effects of recombinant porcine somatotropin (pST) on the requirement for P to maximize lean tissue accretion and to minimize fat tissue accretion in two experiments using finishing pigs. Corn-soybean meal diets with varying levels of P were fed, and Ca was adjusted to maintain a Ca:P ratio of 1.1:1. In Exp. 1, 96 pigs were fed dietary P concentrations of .35, .45, and .65% from 75 to 109 kg BW. One-half of the pigs were injected daily with 4 mg of pST. Administration of pST increased (P < .05) percentages and accretion rates of lean tissue, bone, skin, water, and protein, but it reduced (P < .05) those of fat tissue and lipid. Increasing dietary P had little effect on chemical composition or accretion rates in untreated pigs, but it increased (P < .05) ash percentage and accretion in pigs treated with pST. Experiment 2 consisted of 66 pigs fed six dietary P concentrations (.35, .50, .65, .80, .95, and 1.10%) from 72 to 114 kg. One-half of the pigs were injected daily with 4 mg of pST. Percentages and accretion rates of lean tissue, bone, skin, water, and protein increased (P < .05) with pST, but those of fat tissue and lipid were reduced (P < .05). Increasing dietary P increased accretion rates of bone and skin (linear, P < .05), lean tissue, water, protein, and ash (quadratic, P <.05), and it reduced (quadratic, P < .05) that of lipid in pigs treated with pST. Dietary P level did not consistently affect percentages or accretion rates of tissues or chemical components in untreated pigs. In most instances, pigs treated with pST required higher dietary P levels and greater daily intakes of P to maximize lean tissue and protein deposition and to minimize fat tissue and lipid accretion than untreated pigs. These results indicate that finishing pigs treated with pST require higher dietary percentages of P to maximize carcass lean deposition as compared with untreated pigs.